Used in research settings as a selective antagonist for the CB2 receptor, aiding studies on the endocannabinoid system. Helps investigate inflammation, pain, and immune responses without affecting the central nervous system like CB1-targeting compounds. Commonly applied in preclinical models to explore therapeutic pathways for neurodegenerative diseases, chronic pain, and autoimmune disorders.